Regulatory de novo mutations underlying intellectual disability. (2023)

First Author: De Vas MG
Attributed to:  Targeting etiologic molecular mechanisms to treat human diabetes funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.26508/lsa.202201843

PubMed Identifier: 36854624

Publication URI: http://europepmc.org/abstract/MED/36854624

Type: Journal Article/Review

Volume: 6

Parent Publication: Life science alliance

Issue: 5

ISSN: 2575-1077